NuCana BioMed

NuCana BioMed, a biopharmaceutical company, develops and commercializes rationally designed medicines for significant unmet medical needs.

Business Model:

Revenue: $0

Employees: 11-50

Rankings

Detailed NuCana BioMed Information

Geographic Data

NuCana BioMed headquarters map

Address:

City: Edinburgh

State: Edinburgh, City of

Zip:

Country: United Kingdom

Financial Info

Stage:

post ipo equity

Raised Last:

$80M

Raised Total:

$248M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

NuCana BioMed is an emerging biopharmaceutical company dedicated to the discovery, development and commercialisation of innovative, rationally designed medicines that address significant unmet medical needs. Our management team has extensive experience of building successful biopharmaceutical companies. This includes the formation and subsequent growth of Bioenvision into a NASDAQ National listed, global biopharmaceutical company, which was acquired by Genzyme Corporation in October 2007. Specific management expertise includes the development, approval and commercialisation of oncology medicines. We are developing a portfolio of first-in-class and best-in-class pharmaceutical products designed to treat life-threatening or debilitating diseases. Our primary focus is in the area of oncology, although our technology platform has broader clinical potential.

Contact Phone:

Contact Email:

NuCana BioMed went public on 9/27/2017 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
9/27/2017

IPO Valuation:
$463M

Ticker Symbol:
NCNA

IPO Price:
$15/share

Amount Raised:
$100M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
11/2011 Series A 3 $10.5M Morningside Group
Scottish Enterprise
Sofinnova Partners
Morningside Group
Scottish Enterprise
Sofinnova Partners
9/2017 Post-IPO Equity $100M
4/2014 Series B 2 $57M Scottish Investment Bank
Sofinnova Investments
Scottish Investment Bank
Sofinnova Investments
10/2020 Post-IPO Equity 1 $80M Abingworth
Abingworth
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research